Recovery of serum testosterone following neoadjuvant and adjuvant androgen deprivation therapy in men treated with prostate brachytherapy

Figure 1 Characteristics of the 216 candidates considered for the study. GnRHa: Gonadotropin-releasing hormone agonist therapy; HDR: High-dose rate brachytherapy; EBRT: External beam radiotherapy; AHT: Adjuvant hormonal therapy; NHT: Neoadjuvant hormonal therapy; LDR: Low-dose rate brachytherapy; PSA: Prostate-specific antigen.

Figure 2 Cumulative incidence of testosterone recovery to normal levels (A) and supracastrate levels (B) according to duration of gonadotropin-releasing hormone agonist therapy. Significance (P < 0.05) was determined according to a Log-Rank test.